The bill aims to address public health concerns associated with high THC cannabis products by raising awareness, implementing health interventions, and increasing the minimum legal age for the sale of these products. It introduces new sections that mandate the Department of Health to develop targeted public health campaigns aimed at individuals under 25 and those with mental health challenges, as well as optional training for cannabis retail staff on the health impacts of high THC products. Additionally, the bill amends existing law to prohibit the sale of high THC cannabis products to individuals under 25, with specified penalties for violations, and establishes a timeline for defining "cannabis products with high THC concentrations."

Furthermore, the bill requires the University of Washington's addictions, drug, and alcohol institute to create and evaluate health interventions for at-risk populations, including youth and adults who have experienced cannabis-induced psychosis. The institute is tasked with reporting progress and outcomes of these interventions to the legislature by specified deadlines. The bill also acknowledges the sovereignty of tribal governments, allowing the governor to consult with federally recognized tribes regarding the new age restrictions on cannabis sales. Overall, the legislation seeks to mitigate the risks associated with high THC cannabis use and promote public health through education and intervention.

Statutes affected:
Original Bill: 69.50.357
Substitute Bill: 69.50.357